About Us
Restoring the Function of the Heart to Restore Hope
Heart failure is a progressive disease. It’s an expensive disease. It’s a devastating disease. Over 20% of heart failure patients with FMR die within the first year of diagnosis and 50% die within five years.1 Each year thousands of these patients find the disease has advanced and their options extremely limited.
Cardiac Dimensions’ mission is to give new hope to those suffering from heart failure so they can live longer, higher quality lives.
We’re harnessing our science, technology, and talent to take on this global crisis and improve the survivability for heart failure patients with FMR. Our goal is to treat patients earlier in the disease process—when it’s needed.
And by uniquely treating the underlying causes—not just symptoms.
We are a privately held company headquartered in Kirkland, Washington with operations in the United States, Australia, and Germany.
Leadership Team
The Cardiac Dimensions team is comprised of seasoned veterans with more than 100 years of combined experience in complementary disciplines.
Investors
Cardiac Dimensions is backed by institutional investors with significant domain knowledge, deep industry relationships and a wide network of resources.
- Mozzafarian D, Benjamin EJ, Go AS, et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-e360.
